A Phase I Study to Evaluate LSALT Peptide

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
A phase I double‐blind, placebo‐controlled, randomized, single and multiple ascending dose finding study to evaluate the safety and pharmacokinetic profile of LSALT peptide in healthy participants
Epistemonikos ID: afc9c592da96f78b3dd31181ce2316ffd4a42dd5
First added on: May 21, 2024